Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2017

Mar 3, 2017

31802_dirs_2017-03-03_2e84711d-d984-4750-9add-947363421759.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2017-03-01

Reporting Person: Noznesky Justin J (SVP, Mktg & Business Develop)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-01 Common Stock A 30000 $0.00 Acquired 143565 Direct
2017-03-01 Common Stock F 8386 $18.95 Disposed 135179 Direct

Footnotes

F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 25% annually over four years from date of grant.

F2: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to Restricted Stock Awards.